• Stock watch
• Cannabis
• Health & wellness

TLRY Stock: What to Look for in Tilray’s Q3 Earnings

TLRY stock has fallen below $1 as the cannabis industry awaits legalization updates. Is this a buying opportunity?

02 Apr 2025

• Industry spotlight
• Cannabis

TLRY Stock: Is Tilray a Beer Company Now?

The Tilray share price has underperformed its competitors in 2024 as the indecision over US cannabis reclassification lingers.

21 Aug 2024

• Updates
• Cyber security
• Semiconductors
• Cannabis
• Artificial intelligence

5 Top Stories

Apple Gains Ground in India

Apple’s annual sales in India are at nearly $8bn, a record total, having climbed approximately 33% in the 12 months through March.

16 Jul 2024

• Updates
• Semiconductors
• Electric vehicles
• Health & wellness
• Biotechnology
• Cannabis

5 Top Stories

Record High for TSMC; Tesla Thailand Plan; Big BioVie Offering

The Taiwan Semiconductor Manufacturing Co. share price rose 5.2% to close at NT$725 in Taipei on Monday: its highest-ever level.

04 Mar 2024

• News
• Health & wellness
• Cannabis

Analysis

“A Consumer Goods Story” — Christian Magoon on Cannabis Legalisation

Christian Magoon, CEO of Amplify ETFs, discusses why cannabis legalisation could disrupt the traditional consumer goods sector.

01 Mar 2024

• Fund watch
• Cannabis

Will the AdvisorShares Pure US Cannabis ETF Spike in 2024?

The MSOS fund is on an upward trajectory so far this year, with the reclassification of cannabis potentially on the cards.

22 Jan 2024

• Fund watch
• Cannabis

5 Cannabis Stocks to Watch

A curated collection of stocks to capitalise on opportunities in the cannabis industry.

20 Nov 2023

• News
• Cannabis

Will These Cannabis Stocks Pop on Federal Reform?

The US inched closer to legalising the drug last month, with the US health department advising its classification be lowered.

13 Sep 2023